A synthetic biology company
VALANX has raised €5.3M across 2 funding rounds from 9 investors, most recently a round in Mar 2026. Based in Vienna, Austria; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-03-12 | Other | €3.0M | Angel Investors,Foundation Fournier-Majoie,FUJIFILM Corporation,SkyGene,SOSV,Tecnet equity+2 more | View deal → |
| 2023-11-10 | Other | €2.3M | IST cube,SOSV,Tecnet equity | View deal → |
